Corrigendum: Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma
| dc.contributor.author | Nguyen, Hong Phuong | |
| dc.contributor.author | Le, Anh Quynh | |
| dc.contributor.author | Liu, Enze | |
| dc.contributor.author | Cesarano, Annamaria | |
| dc.contributor.author | DiMeo, Francesco | |
| dc.contributor.author | Perna, Fabiana | |
| dc.contributor.author | Kapur, Reuben | |
| dc.contributor.author | Walker, Brian A. | |
| dc.contributor.author | Tran, Ngoc Tung | |
| dc.contributor.department | Pediatrics, School of Medicine | |
| dc.date.accessioned | 2024-04-17T12:23:35Z | |
| dc.date.available | 2024-04-17T12:23:35Z | |
| dc.date.issued | 2023-11-15 | |
| dc.description.abstract | [This corrects the article DOI: 10.3389/fimmu.2023.1239614.]. | |
| dc.eprint.version | Final published version | |
| dc.identifier.citation | Nguyen HP, Le AQ, Liu E, et al. Corrigendum: Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma. Front Immunol. 2023;14:1334733. Published 2023 Nov 15. doi:10.3389/fimmu.2023.1334733 | |
| dc.identifier.uri | https://hdl.handle.net/1805/40081 | |
| dc.language.iso | en_US | |
| dc.publisher | Frontiers Media | |
| dc.relation.isversionof | 10.3389/fimmu.2023.1334733 | |
| dc.relation.journal | Frontiers in Immunology | |
| dc.rights | Attribution 4.0 International | en |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.source | PMC | |
| dc.subject | PRMT1 | |
| dc.subject | Multiple myeloma | |
| dc.subject | Relapsed/refractory myeloma | |
| dc.subject | Targeted therapy | |
| dc.subject | Xenograft model | |
| dc.title | Corrigendum: Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma | |
| dc.type | Article |